Conference spotlight and recent price slide put AptarGroup in focus

AptarGroup (ATR) is in the spotlight as CFO Vanessa Kanu speaks at back to back Jefferies healthcare and Wells Fargo industrials conferences, at the same time that the stock has fallen about 6% over the past month.

That recent 6% slide over the month and 12.2% 90 day share price return decline sits against a 1 year total shareholder return down 22.9%, while the 3 year total shareholder return of 4.6% hints at a more mixed longer term picture.

If recent conference appearances have you reassessing your portfolio, this could be a good time to widen the lens and uncover 20 top founder-led companies

With AptarGroup trading below some estimates of fair value while still facing higher legal costs and softer demand in parts of pharma and beauty, is this recent slide a buying opportunity or is the market already pricing in future growth?

Most Popular Narrative: 28.2% Undervalued

The most followed narrative values AptarGroup at $161.43 per share, compared with the last close at $115.90. This sets up a clear valuation gap for investors to interrogate.

Operational efficiency programs including segment integration, global supply chain optimization, and robust digital transformation are already delivering gross margin and SG&A improvements, which supports ongoing EBITDA margin expansion and enhanced long-term earnings power.

Curious what has to happen in pharma platforms, beauty dispensing and margins to justify that higher valuation anchor? The narrative leans on steady growth, richer mix and a future earnings multiple that assumes confidence in those projections. The full breakdown shows how each of these pieces is modeled to arrive at that fair value number.

Result: Fair Value of $161.43 (UNDERVALUED)

However, you still need to weigh up rising legal expenses around intellectual property disputes, as well as softer demand in areas like emergency medicine and consumer healthcare sprays.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View: Earnings Multiple Sends A Different Signal

While the SWS DCF model suggests AptarGroup is trading 46.4% below estimated future cash flow value at $216.29, the P/E story is less generous. At 19.1x, the stock sits above the global packaging industry at 15x, peers at 15.3x, and even the 18.2x fair ratio. This points to some valuation risk if sentiment cools.

For a clearer sense of how those cash flow assumptions are built and where they could be wrong, it helps to see the full calculation in context, not just the headline discount, via the Look into how the SWS DCF model arrives at its fair value.

Next Steps

If this mix of cautious and optimistic signals feels familiar, do not wait on others to decide for you. Instead, weigh the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If this AptarGroup story has you rethinking your next move, do not stop here. Broaden your watchlist with a few more focused angles worth your attention.

• Target dependable income by reviewing 9 dividend fortresses which may appeal if you care about recurring cash returns from established businesses.
• Hunt for value by scanning 46 high quality undervalued stocks where solid fundamentals and pricing gaps could offer interesting entry points.
• Prioritise resilience by assessing 63 resilient stocks with low risk scores which score well on financial strength and lower overall risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.